ARAAF vs. OVID

Last updated Apr 1, 2026

Compare and contrast key facts about Aclara Resources Inc (ARAAF) and Ovid Therapeutics Inc. (OVID).

Performance

ARAAF vs. OVID - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Aclara Resources Inc (ARAAF) and Ovid Therapeutics Inc. (OVID). The values are adjusted to include any dividend payments, if applicable.

ARAAF vs. OVID - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021
ARAAF Aclara Resources Inc	50.62%	404.63%	-11.58%	49.59%	-78.68%	-7.97%
OVID Ovid Therapeutics Inc.	36.20%	74.57%	-71.00%	73.12%	-42.06%	1.90%

Fundamentals

EPS ARAAF : -$0.07 OVID : -$0.23
Total Revenue (TTM) ARAAF : $0.00 OVID : $7.25M
Gross Profit (TTM) ARAAF : -$1.03M OVID : $6.52M
EBITDA (TTM) ARAAF : -$8.60M OVID : -$41.82M

Returns By Period

In the year-to-date period, ARAAF achieves a 50.62% return, which is significantly higher than OVID's 36.20% return.

ARAAF

• 1D: 3.66%
• 1M: -2.50%
• YTD: 50.62%
• 6M: 27.90%
• 1Y: 591.57%
• 3Y*: 98.97%
• 5Y*: —
• 10Y*: —

OVID

• 1D: 5.21%
• 1M: 36.20%
• YTD: 36.20%
• 6M: 70.77%
• 1Y: 611.77%
• 3Y*: -4.89%
• 5Y*: -11.42%
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

Return for Risk

ARAAF vs. OVID — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ARAAF

ARAAF Risk / Return Rank: 97
ARAAF Sharpe Ratio Rank: 99
ARAAF Sortino Ratio Rank: 97
ARAAF Omega Ratio Rank: 95
ARAAF Calmar Ratio Rank: 98
ARAAF Martin Ratio Rank: 97

OVID

OVID Risk / Return Rank: 98
OVID Sharpe Ratio Rank: 99
OVID Sortino Ratio Rank: 98
OVID Omega Ratio Rank: 95
OVID Calmar Ratio Rank: 99
OVID Martin Ratio Rank: 99

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

ARAAF vs. OVID - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Aclara Resources Inc (ARAAF) and Ovid Therapeutics Inc. (OVID). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	ARAAF	OVID	Difference
Sharpe ratio Return per unit of total volatility	5.09	5.34	-0.25
Sortino ratio Return per unit of downside risk	4.12	4.38	-0.25
Omega ratio Gain probability vs. loss probability	1.50	1.53	-0.03
Calmar ratio Return relative to maximum drawdown	9.83	15.36	-5.53
Martin ratio Return relative to average drawdown	20.71	36.14	-15.43
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

ARAAF vs. OVID - Sharpe Ratio Comparison

The current ARAAF Sharpe Ratio is 5.09, which is comparable to the OVID Sharpe Ratio of 5.34. The chart below compares the historical Sharpe Ratios of ARAAF and OVID, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Sharpe Ratios by Period

	ARAAF	OVID	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	5.09	5.34	-0.25
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	—	-0.14	—
Sharpe Ratio (All Time) Calculated using the full available price history	0.15	-0.20	+0.35

Correlation

The correlation between ARAAF and OVID is 0.06, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Dividends

ARAAF vs. OVID - Dividend Comparison

Neither ARAAF nor OVID has paid dividends to shareholders.

Tickers have no history of dividend payments

Drawdowns

ARAAF vs. OVID - Drawdown Comparison

The maximum ARAAF drawdown since its inception was -84.58%, smaller than the maximum OVID drawdown of -98.30%. Use the drawdown chart below to compare losses from any high point for ARAAF and OVID.

Drawdown Indicators

	ARAAF	OVID	Difference
Max Drawdown Largest peak-to-trough decline	-84.58%	-98.30%	+13.72%
Max Drawdown (1Y) Largest decline over 1 year	-56.89%	-34.78%	-22.11%
Max Drawdown (5Y) Largest decline over 5 years	—	-94.32%	—
Current Drawdown Current decline from peak	-30.23%	-85.20%	+54.97%
Average Drawdown Average peak-to-trough decline	-60.21%	-74.97%	+14.76%
Ulcer Index Depth and duration of drawdowns from previous peaks	26.99%	14.79%	+12.20%

Volatility

ARAAF vs. OVID - Volatility Comparison

Aclara Resources Inc (ARAAF) and Ovid Therapeutics Inc. (OVID) have volatilities of 27.64% and 28.41%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	ARAAF	OVID	Difference
Volatility (1M) Calculated over the trailing 1-month period	27.64%	28.41%	-0.77%
Volatility (6M) Calculated over the trailing 6-month period	85.42%	67.08%	+18.34%
Volatility (1Y) Calculated over the trailing 1-year period	117.53%	116.26%	+1.27%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	120.10%	79.41%	+40.69%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	120.10%	86.04%	+34.06%

Financials